Invention Grant
- Patent Title: Anti-IGF-IR antibodies and uses thereof
- Patent Title (中): 抗IGF-1R抗体及其用途
-
Application No.: US13745142Application Date: 2013-01-18
-
Publication No.: US08945871B2Publication Date: 2015-02-03
- Inventor: Liliane Goetsch , Nathalie Corvaia
- Applicant: Pierre Fabre Medicament
- Applicant Address: FR Boulogne-Billancourt
- Assignee: Pierre Fabre Medicament
- Current Assignee: Pierre Fabre Medicament
- Current Assignee Address: FR Boulogne-Billancourt
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: FR0507829 20050722
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K14/705 ; C07K16/46 ; A61K39/395 ; A61K39/00
Abstract:
The present invention relates to novel antibodies capable of binding specifically to the human insulin-like growth factor I receptor (IGF-IR). The invention likewise comprises the use of these antibodies as a medicament for the prophylactic and/or therapeutic treatment of cancers overexpressing IGF-IR, stimulated either by IGF1 and/or IGF2, or any pathology connected with the overexpression of said receptor as well as in processes or kits for diagnosis of illnesses connected with the overexpression of the IGF-IR and/or the IGF-I/Insulin hybrid receptor.
Public/Granted literature
- US20130125252A1 NOVEL ANTI-IGF-IR ANTIBODIES AND USES THEREOF Public/Granted day:2013-05-16
Information query
